Big Pharma: Is Paying Big Fines More Profitable than Telling Doctors and Consumers the Truth in Marketing?

This week, Johnson & Johnson etched its name in the history books of another big pharma company that has been fined over billions of dollars due to a drug manufacturer practices of improper marketing and failure to warn.  Johnson & Johnson pled guilty to claims stemming from allegations that the giant pharmaceutical company knowingly marketed [...]

By | November 7th, 2013|Actos Diabetes Drug, Avandia Diabetes Drug, DePuy Hip Replacement, Drug and Medical Device Litigation, Fosamax Osteoporosis Drug, Lipitor, Transvaginal Mesh|Comments Off on Big Pharma: Is Paying Big Fines More Profitable than Telling Doctors and Consumers the Truth in Marketing?

United Kingdom Seeks to Eliminate the Use of Metal-on-Metal Implants Due to High Failure Rate

Because of the high failure rates of metal on metal hip devices, and the potential for toxic exposure, the United Kingdom is moving to ban all metal-on-metal hip replacements performed at National Health Service [NHS] hospitals.  NHS is the publicly funded health care system in the U.K, the NHS seeks to stop these surgeries with [...]

By | November 1st, 2013|DePuy Hip Replacement, Drug and Medical Device Litigation|Comments Off on United Kingdom Seeks to Eliminate the Use of Metal-on-Metal Implants Due to High Failure Rate

DePuy September 23, 2013 Bellwether Trial Continued

On September 20, the Honorable David Katz presiding over the DePuy bellwether case, Ann McCracken v. DePuy Orthopaedics, Inc., et. al., Case No. 11 dp 20485, continued the trial 90 days from September 24, 2013 “in the interest of justice”.  According to the Order, the Judge continued the trial so that the parties could complete [...]

By | September 23rd, 2013|DePuy Hip Replacement, Drug and Medical Device Litigation|Comments Off on DePuy September 23, 2013 Bellwether Trial Continued

Johnson & Johnson Recalls Another DePuy Orthopedic Product

Johnson & Johnson (J&J) is no stranger to controversy.  From being embroiled in massive litigation in DePuy ASR artificial hips, Pinnacle litigation, and in the transvaginal mesh litigation with its Ethicon Gynecare products to its multiple legal troubles and fines associated with the anti-psychotic drug Risperdal, some things do not change for J&J – they [...]

By | August 2nd, 2013|DePuy Hip Replacement, Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Johnson & Johnson Recalls Another DePuy Orthopedic Product

510(k); Pathway for Safer drugs or Recipe for Disaster

Recent medical disasters such as the DePuy ASR, DePuy Pinnacle, and transvaginal mesh cases have revealed that medical devices were approved for use without adequate clinical data based on a grandfathering type provision in the FDA called a 510(k) process, where a new device that is cleared as "substantially equivalent" as a previously approved device [...]

By | June 3rd, 2013|DePuy Hip Replacement, Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on 510(k); Pathway for Safer drugs or Recipe for Disaster

Are Too Many Doctors Simply Sales People for Big Pharma?

Big Pharma paid doctors more than $1 billion in 2012 to act in various spokesperson capacities, for travel and meals, as well as research and royalties, which is significantly more than reported in 2011.  According to a new data reported in the Financial Times, that figure only includes the 12 leading drug makers who actually [...]

By | May 29th, 2013|DePuy Hip Replacement, Drug and Medical Device Litigation, Fosamax Osteoporosis Drug, Transvaginal Mesh|Comments Off on Are Too Many Doctors Simply Sales People for Big Pharma?

Who is Responsible for J&J’s DePuy ASR, Pinnacle, Ethicon’s Gynecare, and Merck’s Vioxx and Fosamax?

Consumers injured by defective devices face an armada of attorneys as they seek to hold accountable device makers such as J&J’s hip implants DePuy ASR, DePuy Pinnacle, J&J’s transvaginal mesh product Ethicon, and Merck’s FOSAMAX that has left countless post menopausal women with atypical femur fractures.  Currently there are over 10,000 pending cases in the [...]

By | May 28th, 2013|Actos Diabetes Drug, DePuy Hip Replacement, Drug and Medical Device Litigation, Fosamax Osteoporosis Drug, Transvaginal Mesh|Comments Off on Who is Responsible for J&J’s DePuy ASR, Pinnacle, Ethicon’s Gynecare, and Merck’s Vioxx and Fosamax?

J&J’s DePuy Unit Abandons Pinnacle and All Metal Hip Implants

On May 16, 2013, in what many health advocates feel is a long overdue move, J&J’s DePuy Orthopedic unit announced it was stopping the manufacture of all metal replacement hips.  In August 2010 the unit recalled the DePuy ASR in the face of mounting evidence of high failure rates but continued to sell the all [...]

By | May 17th, 2013|DePuy Hip Replacement, Drug and Medical Device Litigation|Comments Off on J&J’s DePuy Unit Abandons Pinnacle and All Metal Hip Implants

Risperdal adds to DePuy and Ethicon Troubles for J&J

Johnson and Johnson (J&J), already embroiled in massive litigation in DePuy ASR artificial hips, and in the trans vaginal mesh litigation from its Ethicon Gynecare products, faces another significant issue over its mounting legal troubles stemming from its antipsychotic drug Risperdal.  The drug was approved in 1993 for use in adults and was also later [...]

By | May 12th, 2013|DePuy Hip Replacement, Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Risperdal adds to DePuy and Ethicon Troubles for J&J

Medical Device Reporting for People Injured by Vaginal Mesh, Actos, Fosamax, and DePuy ASRs: What the Consumer Needs to Know

Manufacturers, user facilities and importers of medical devices are mandated to submit certain adverse events to the U.S. Food and Drug Administration [FDA].  Medical device reporting requires that manufacturers report to the FDA when they learn that one of their devices may have contributed to a death or serious injury.  Consumers and health professionals can [...]

By | April 26th, 2013|Actos Diabetes Drug, DePuy Hip Replacement, Drug and Medical Device Litigation, Fosamax Osteoporosis Drug, Transvaginal Mesh|Comments Off on Medical Device Reporting for People Injured by Vaginal Mesh, Actos, Fosamax, and DePuy ASRs: What the Consumer Needs to Know